Cytomegalovirus Retinitis During Idecabtagene Vicleucel Therapy in Patients With Relapsed/Refractory Multiple Myeloma
CMV retinitis is a significant complication of ide-cel therapy. Regular CMV PCR is important, but early ophthalmological consultations are crucial for timely detection and management, even in the absence of CMV replication, particularly when visual impairment develops. Further studies are needed to identify the risk factors and establish preventive strategies.
Authors
- Taku Kikuchi (ORCID: https://orcid.org/0000-0002-3210-7756)
- Kenshi Suzuki (ORCID: https://orcid.org/0000-0001-7132-5337)
- Kota Sato (ORCID: https://orcid.org/0000-0001-9239-6003)
- Osamu Hosoya
- Chiaki Matsumoto (ORCID: https://orcid.org/0000-0002-6505-593X)
- Miyu Watanabe
- Hitoshi Sawada (ORCID: https://orcid.org/0000-0003-4363-7696)
- Tomomi Takei (ORCID: https://orcid.org/0000-0002-0422-0030)
- Tadao Ishida
- Yu Abe (ORCID: https://orcid.org/0000-0003-3982-0578)
- Kodai Kunisada
- Moe Nomura‐Yogo
- Nobuhiro Tsukada (ORCID: https://orcid.org/0000-0003-2914-2670)
- Mizuki Ogura
Institutions
- Japanese Red Cross Medical Center (JP)
Publication Details
- Journal
- Transplant Infectious Disease
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1111/tid.70040
- Citations
- 4
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 5.42